INCYTE CORP - 03 Nov 2025 SCHEDULE 13G Report for Prelude Therapeutics, Inc. Common Stock, par value $0.0001 per share (PRLD)

Filing Manager: INCYTE CORP
Reporting Manager: INCYTE CORP
Security: Prelude Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: PRLD
Shares outstanding: 44.2M shares
Disclosed Ownership: 4.37M shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 07 Nov 2025, 16:01:48 UTC
Date of event: 03 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
INCYTE CORP	9.9%	4.37M	4.37M	0	/s/ Sheila A. Denton	Sheila A. Denton / Executive Vice President and General Counsel